Bioperfectus Acquired ISO 9001:2015 Certification

Company news
2022-03-25

Shanghai, China, March 25th, 2022—As one of the leading in-vitro diagnostic manufacturers on infectious diseases globally, Bioperfectus solemnly announced that we acquired ISO 9001: 2015 Certification.

 

It is another recognition of our company quality management system in the international stage besides ISO 13485.”, said Bioperfectus International Sales & Marketing Division Deputy General Manager.

 

Bioperfectus has formerly obtained ISO 13485, which sets for medical devices company in the quality management system for regulatory purpose. The objective of ISO 9001 is to provide a set of requirements that, if effectively implemented, will give the endorsement of the company’s products and services:

  •  Meet customers’ needs and expectations
  •  Comply with applicable regulations

 

 

About ISO 9001: 2015 Certification

ISO 9001 is an International Standard that gives an organization’s quality management system (QMS) requirements. It is part of a family of standards published by the International Organization for Standardization (ISO) and often referred to collectively as theISO 9000 series” or “ISO 9000 family”. To learn more, please click here 


About Bioperfectus

Bioperfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), has been one of the leading molecular diagnostic solution providers specialized in infectious diseases ever since 2010. With headquarters located in Jiangsu, subsidiaries in Shanghai, Beijing, Xi'an, Taizhou, Hainan, and Yinchuan. Bioperfectus is pioneering in the molecular diagnostics market with our products ranging from real-time PCR kits, nucleic acid extraction systems, rapid tests, and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream to create a healthier future for our next generations. 

MOST READ

Tick-Borne Diseases: Understanding, Prevention, and Diagnosis

Tick-borne diseases pose a substantial burden on global health, necessitating urgent attention. Addressing the challenge of tick-borne illnesses is crucial for ensuring the protection of public health worldwide.

2023-06-02

Celebrating Three Years of International Growth and Success at BioPerfectus

Today, we spotlight the remarkable journey of BioPerfectus's global footprint, a testament to our significant growth and expansion.

2023-06-01

BioPerfectus Launches New PCR Kit for STD Diagnostic Solution

BioPerfectus announces the CE marking of one new product: Herpes Simplex Virus Type I/II Real Time PCR Kit.

2023-04-27